$11.950
+0.632 (+5.29%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de FDMT por análisis de gráficos similares
Alphio's FDMT stock price prediction model matches the current 4D Molecular Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.88 (-0.60%). The 1-week path is $11.63 (-2.66%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de 4D Molecular Therapeutics Inc?
Currently, 4D Molecular Therapeutics Inc is not a strong buy due to its low RSI of 37.91, indicating potential oversold conditions, and a forward P/E ratio of 0, suggesting uncertainty in future earnings. However, the stock has shown a year-to-date change of +55.05%, indicating strong performance this year. The main risk is the significant net income loss reported in the latest quarter, amounting to -68.76 million USD, which raises concerns about the company's profitability moving forward.
FDMT cerró en $11.95 el Tuesday, tras subir +5.29%
4D Molecular Therapeutics Inc (FDMT) last closed at $11.9499998, gaining +5.29%. These facts feed the 1-day and 1-week FDMT price prediction above.
Factores de la previsión
Los factores de la previsión de 4D Molecular Therapeutics Inc (FDMT) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de FDMT, ordenadas por similitud.
Análisis de estacionalidad de FDMT
Historically the probability of a positive November return for FDMT is 51.22%. February offers the highest probability of a positive month at 72.41%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.